Capturing the stem cell paracrine effect using heparin‐presenting nanofibres to treat cardiovascular diseases
暂无分享,去创建一个
S. Stupp | M. Webber | Xiaoqiang Han | S. Prasanna Murthy | K. Rajangam | J. Lomasney | Kanya Rajangam | Xiaoqiang Han | Matthew J. Webber | S. N. Prasanna Murthy | Samuel I. Stupp | Jon W. Lomasney
[1] D. Bodine,et al. Transplanted Adult Bone Marrow Cells Repair Myocardial Infarcts in Mice , 2001, Annals of the New York Academy of Sciences.
[2] B. Fleischmann,et al. Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.
[3] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[4] Florian Tögel,et al. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. , 2008, American journal of physiology. Renal physiology.
[5] Kamil Ugurbil,et al. Oxidative capacity in failing hearts. , 2003, American journal of physiology. Heart and circulatory physiology.
[6] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[7] Zhi-Sheng Jiang,et al. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. , 2004, Cardiovascular research.
[8] J. Schlessinger,et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.
[9] L. Field. Unraveling the mechanistic basis of mesenchymal stem cell activity in the heart. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] G. Waksman,et al. Heparin-induced Self-association of Fibroblast Growth Factor-2 , 1997, The Journal of Biological Chemistry.
[11] Robert G Weiss,et al. Is the failing heart energy starved? On using chemical energy to support cardiac function. , 2004, Circulation research.
[12] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[13] A. From,et al. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. , 1999, Circulation.
[14] W. Baumgartner,et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.
[15] M. Rubart,et al. Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] M. Entman,et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.
[17] Paul D. Kessler,et al. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.
[18] X. Qin,et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. , 2005, The Annals of thoracic surgery.
[19] J. Hare,et al. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche , 2007, Nature Clinical Practice Cardiovascular Medicine.
[20] Samuel I Stupp,et al. Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. , 2005, Acta biomaterialia.
[21] Stefan Neubauer,et al. The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.
[22] K. Kuck,et al. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism? , 2005, Stem cells and development.
[23] M. Pittenger,et al. Mesenchymal stem cells and their potential as cardiac therapeutics. , 2004, Circulation research.
[24] H. Ohgushi,et al. Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy , 2005, Circulation.
[25] S. Houser,et al. Bone marrow cells adopt the cardiomyogenic fate in vivo , 2007, Proceedings of the National Academy of Sciences.
[26] F. Tögel,et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. , 2005, Kidney international.
[27] Mark A Sussman,et al. Bones of contention: marrow-derived cells in myocardial regeneration. , 2008, Journal of molecular and cellular cardiology.
[28] Michael S. Arnold,et al. Peptide amphiphile nanostructure-heparin interactions and their relationship to bioactivity. , 2008, Biomaterials.
[29] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Stupp,et al. Self-Assembly and Mineralization of Peptide-Amphiphile Nanofibers , 2001, Science.
[31] M. Klagsbrun. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. , 1992, Seminars in cancer biology.
[32] S. Homma,et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.
[33] Lina A. Thoren,et al. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion , 2008, Nature Cell Biology.
[34] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[35] J. Isner,et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.
[36] Robert L Wilensky,et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. , 2006, European heart journal.
[37] Z. Popović,et al. SDF‐1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] R. Shannon,et al. Recombinant Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake and Improves Left Ventricular Performance in Conscious Dogs With Pacing-Induced Dilated Cardiomyopathy , 2004, Circulation.
[39] V. Dilsizian,et al. Metabolic Imaging With &bgr;-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia , 2005, Circulation.
[40] C. Lange,et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. , 2005, American journal of physiology. Renal physiology.
[41] David A. Williams,et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.
[42] H. Taegtmeyer. Cardiac metabolism as a target for the treatment of heart failure. , 2004, Circulation.
[43] Y. Yoon,et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. , 2005, The Journal of clinical investigation.
[44] Samuel I Stupp,et al. Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] Fei Ye,et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. , 2004, Chinese medical journal.
[46] Douglas L Mann,et al. Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.
[47] Qing-ping Li,et al. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. , 2007, Biochemical and biophysical research communications.
[48] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[49] Mingyao Liu,et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium , 2004, Regulatory Peptides.
[50] Samuel I Stupp,et al. Heparin binding nanostructures to promote growth of blood vessels. , 2006, Nano letters.
[51] Fulvio Mavilio,et al. Gene therapy , 1993, Nature.
[52] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[53] C James Kirkpatrick,et al. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. , 2009, Biomaterials.
[54] A. Caplan,et al. Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.
[55] R. Burt,et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. , 2008, JAMA.